Secondly, we detected an augmented baseline IFN-γ signature in BRCA1-mutated cancer and primary epithelial cells and tumors coupled with decreased cytotoxicity induced by IFN-γ or by STAT1 knockdown. The gene discussed is BRCA1; the disease is cancer.